Viking Therapeutics, Inc. (VKTX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92686J1060
Viking Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -393.34 m USD |
| EBIT | -359.64 m USD |
| Net income | -359.64 m USD |
| Diluted EPS – continuing operations | -3.19 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
More stocks
- Catcher Technology Co Ltd (2474.TW)
- PROVIDENT FINANCIAL SERVICES INC (PFS)
- CECO ENVIRONMENTAL CORP (CECO)
- AtriCure, Inc. (ATRC)
- Clas Ohlson AB (CLAS B.ST)
- SiriusPoint Ltd (SPNT)
- Miniso Group Holding Ltd (MNSO)
- Wuxi Taclink Optoelectronics Technology Co. Ltd. A (688205.SS)
- Enav SpA (ENAV.MI)
- Nagase & Co Ltd (8012.T)
- WillScot Holdings Corp (WSC)
- Unilever Indonesia Tbk (UNVR.JK)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.